XML 91 R8.htm IDEA: XBRL DOCUMENT v3.24.0.1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
 9 Months Ended
Jan. 31, 2024
Jan. 31, 2023
Cash flows from operating activities:    
Net earnings $ 7,878 $ 265
Adjustments to reconcile net earnings to net cash provided by (used in) operating activities:    
Depreciation 2,305 2,142
Bad debt provision 227 79
Stock-based compensation expense 665 699
Deferred income taxes 191 368
Change in assets and liabilities:    
Receivables 4,745 (2,813)
Inventories 44 2,384
Accounts payable and other accrued expenses (3,842) (4,534)
Deferred revenue 6,151 1,533
Other, net 55 (3,670)
Net cash provided by (used in) operating activities 18,419 (3,547)
Cash flows from investing activities:    
Capital expenditures (3,394) (1,562)
Net cash used in investing activities (3,394) (1,562)
Cash flows from financing activities:    
Proceeds from short-term borrowings 112,316 27,742
Repayments on short-term borrowings (112,718) (23,577)
Proceeds from sale-leaseback financing transaction 0 13,473
Payments on sale-leaseback financing transaction (476) (426)
Proceeds from long-term lease obligations 202 0
Payments on long-term lease obligations (78) (123)
Purchase of treasury stock (791) 0
Net cash (used in) provided by financing activities (1,545) 17,089
Effect of exchange rate changes on cash, cash equivalents and restricted cash (183) (458)
Increase in cash, cash equivalents and restricted cash 13,297 11,522
Cash, cash equivalents and restricted cash, beginning of period 13,815 6,894
Cash, cash equivalents and restricted cash, end of period $ 27,112 $ 18,416